A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of PF-06678552 After Fed And Fasted Administration Of Single Escalating Oral Doses In Healthy Subjects

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of PF-06678552 After Fed And Fasted Administration Of Single Escalating Oral Doses In Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 02 May 2014

At a glance

  • Drugs PF 6678552 (Primary)
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 02 May 2014 According to ClinicalTrials.gov record, status changed from recruiting to completed.
    • 13 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 04 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top